FDA Approved: OCTREOTIDE ACETATE — Original Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved the original ANDA for octreotide acetate from Mylan Institutional LLC. This marks the generic approval for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Carcinoid Syndrome
• Esophageal Variceal Bleeding
• Neuroendocrine Tumors
• Vasoactive Intestinal Peptide-secreting Tumor

Drugs mentioned

• OCTREOTIDE ACETATE (octreotide acetate)

Snippet

ORIG AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)